HSPB1 and breast carcinoma: Consistently, our results also demonstrated that HSPB1 could bind with IKβ-α and promote ubiquitination-mediated IKβ-α degradation, leading to enhanced nuclear translocation and activity of NF-κB in breast cancer cells.